Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Medicine
|
July 27, 2023
Treatment of pediatric spasticity, including children with cerebral palsy, with Botox (onabotulinumtoxinA): Development, insights, and impact
Mark Gormley, Henry G Chambers, Heakyung Kim, et al.
Neurosurgical Focus
|
November 1, 2020
Litigation risks despite guideline adherence for acute spinal cord injury: time is spine
Daniel Rafter, Ranveer Vasdev, Duncan Hurrelbrink, et al.
Neurorehabilitation
|
August 2, 2021
Efficacy and safety of onabotulinumtoxinA with standardized occupational therapy for treatment of pediatric upper limb spasticity: Phase III placebo-controlled randomized trial
Rozalina Dimitrova, Emily McCusker, Mark Gormley, et al.
BMJ Open
|
May 4, 2022
Metabolic disorders and the risk of head and neck cancer: a protocol for a systematic review and meta-analysis
Alexander Gormley, Charlotte Richards, Francesca Spiga, et al.
Journal of Pediatric Rehabilitation Medicine
|
March 11, 2022
Needlepoints: Clinical approach to child living with cerebral palsy
Michael M Green, Heakyung Kim, Ruth Gauden, et al.
Developmental Neurorehabilitation
|
November 7, 2019
Efficacy of Repeat AbobotulinumtoxinA (Dysport®) Injections in Improving Gait in Children with Spastic Cerebral Palsy
Nigar Dursun, Marcin Bonikowski, Edward Dabrowski, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
September 28, 2016
Poster 485 Safety and Tolerability of AbobotulinumtoxinA (Dysport) in Children (2-17 Years) with Lower Limb Spasticity Due to Cerebral Palsy: A Pooled Analysis of 8 Clinical Trials
Dennis Matthews, George C Camba, Ignacio Pascual-Pascual, et al.
Journal of Child Neurology
|
December 24, 2024
Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Pediatric Upper and Lower Limb Spasticity: Results From 2 Open-Label, Long-term Extension Trials
Mark Gormley, Darcy Fehlings, Heakyung Kim, et al.
Elife
|
April 12, 2023
Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using Mendelian randomization
Mark Gormley, Tom Dudding, Steven J Thomas, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Reassessing the link between adiposity and head and neck cancer: a Mendelian randomization study
Fernanda Morales-Berstein, Jasmine Khouja, Mark Gormley, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Medicine
|
July 27, 2023
Treatment of pediatric spasticity, including children with cerebral palsy, with Botox (onabotulinumtoxinA): Development, insights, and impact
Mark Gormley, Henry G Chambers, Heakyung Kim, et al.
Neurosurgical Focus
|
November 1, 2020
Litigation risks despite guideline adherence for acute spinal cord injury: time is spine
Daniel Rafter, Ranveer Vasdev, Duncan Hurrelbrink, et al.
Neurorehabilitation
|
August 2, 2021
Efficacy and safety of onabotulinumtoxinA with standardized occupational therapy for treatment of pediatric upper limb spasticity: Phase III placebo-controlled randomized trial
Rozalina Dimitrova, Emily McCusker, Mark Gormley, et al.
BMJ Open
|
May 4, 2022
Metabolic disorders and the risk of head and neck cancer: a protocol for a systematic review and meta-analysis
Alexander Gormley, Charlotte Richards, Francesca Spiga, et al.
Journal of Pediatric Rehabilitation Medicine
|
March 11, 2022
Needlepoints: Clinical approach to child living with cerebral palsy
Michael M Green, Heakyung Kim, Ruth Gauden, et al.
Developmental Neurorehabilitation
|
November 7, 2019
Efficacy of Repeat AbobotulinumtoxinA (Dysport®) Injections in Improving Gait in Children with Spastic Cerebral Palsy
Nigar Dursun, Marcin Bonikowski, Edward Dabrowski, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation
|
September 28, 2016
Poster 485 Safety and Tolerability of AbobotulinumtoxinA (Dysport) in Children (2-17 Years) with Lower Limb Spasticity Due to Cerebral Palsy: A Pooled Analysis of 8 Clinical Trials
Dennis Matthews, George C Camba, Ignacio Pascual-Pascual, et al.
Journal of Child Neurology
|
December 24, 2024
Efficacy and Safety of OnabotulinumtoxinA for the Treatment of Pediatric Upper and Lower Limb Spasticity: Results From 2 Open-Label, Long-term Extension Trials
Mark Gormley, Darcy Fehlings, Heakyung Kim, et al.
Elife
|
April 12, 2023
Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using Mendelian randomization
Mark Gormley, Tom Dudding, Steven J Thomas, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Reassessing the link between adiposity and head and neck cancer: a Mendelian randomization study
Fernanda Morales-Berstein, Jasmine Khouja, Mark Gormley, et al.
Page
of 5